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Abstract
Background: Cognitive models of depression suggest that major depression is characterized by biased facial
emotion processing, making facial stimuli particularly valuable for neuroimaging research on the neurobiological
correlates of depression. The present review provides an overview of functional neuroimaging studies on abnormal
facial emotion processing in major depression. Our main objective was to describe neurobiological differences
between depressed patients with major depressive disorder (MDD) and healthy controls (HCs) regarding brain
responsiveness to facial expressions and, furthermore, to delineate altered neural activation patterns associated
with mood-congruent processing bias and to integrate these data with recent functional connectivity results. We
further discuss methodological aspects potentially explaining the heterogeneity of results.
Methods: A Medline search was performed up to August 2011 in order to identify studies on emotional face
processing in acutely depressed patients compared with HCs. A total of 25 studies using functional magnetic
resonance imaging were reviewed.
Results: The analysis of neural activation data showed abnormalities in MDD patients in a common face
processing network, pointing to mood-congruent processing bias (hyperactivation to negative and hypoactivation
to positive stimuli) particularly in the amygdala, insula, parahippocampal gyrus, fusiform face area, and putamen.
Furthermore, abnormal activation patterns were repeatedly found in parts of the cingulate gyrus and the
orbitofrontal cortex, which are extended by investigations implementing functional connectivity analysis. However,
despite several converging findings, some inconsistencies are observed, particularly in prefrontal areas, probably
caused by heterogeneities in paradigms and patient samples.
Conclusions: Further studies in remitted patients and high-risk samples are required to discern whether the
described abnormalities represent state or trait characteristics of depression.
Keywords: Facial emotion processing, fMRI, neuroimaging, depression, emotion, amygdala, anterior cingulate, orbi-
tofrontal cortex, functional connectivity
Background
Major depression ranks among the most debilitating dis-
eases worldwide and is estimated to produce the second
largest disease burden by the year 2020 [1]. Despite an
increasing amount of empirical studies investigating
abnormalities in affective processing in unipolar depres-
sion, understanding the neurobiological underpinnings
is still a major research goal and is essential for novel
treatment developments. In a large body of behavioral
studies, depression has been characterized by mood con-
gruent emotion processing bias e si nd i f f e r e n ta s p e c t so f
cognition [2-5]. Apparently, these cognitive biases have
been reported to be particularly prominent for emo-
tional faces. Depressed patients seem to be less sensitive
in the identification of emotional faces and, in addition,
a negative response bias was found: they tend to inter-
pret neutral faces as sad and happy faces as neutral (for
review see [6,7]).
While negative faces seem to be processed more
rapidly and deeply, processing of positive facial expres-
sions appears to be impaired [8-10]. Furthermore, beha-
vioral biases towards sad faces seem to persist even after
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future depressive episodes [12]. Interestingly, rapid,
automatic stages of emotion processing are also affected
in depression, as suggested by studies employing sublim-
inal presentation conditions [13,14]. Figure 1 presents
the main emotion processing stages as supposed by
Phillips et al. [15], extended about separate pathways for
stimulus presentation with or without conscious
awareness.
Faces are a very important component of daily human
visual communication. Since the processing of facial
expressions is a fundamental step in social functioning,
guiding adequate social interaction [16], biased proces-
sing of emotional faces in depression could be a strong
determinant of the frequently observed interpersonal
problems, including social withdrawal, feelings of inter-
personal rejection and restriction of non-verbal expres-
siveness [17].
Brain imaging techniques, such as functional magnetic
resonance imaging (fMRI), have already made substan-
tial contributions to the understanding of how faces and
facial expressions are processed in humans [18-21].
According to neurobiological models of emotional face
processing, successful encoding of emotional expressions
depends on multiple interactions between complimen-
tary systems: a neural core system for the visual analysis
of faces consists of the bilateral inferior occipital gyrus,
the lateral fusiform gyrus and the superior temporal sul-
cus. Changeable and invariant aspects of the face repre-
sentation have distinct representations in this system. A
second, extended system supports the processing of
facial information such as meaning and significance. It
is composed of additional brain areas generally involved
in representing and producing emotions. Major compo-
nents include the amygdala, insula, orbitofrontal areas
and somatosensory cortex [22]. Notably, most if not all
of these areas have already been implicated in the etiol-
ogy of major depression (see [23-25] for reviews). Thus,
presenting facial emotional stimuli is a valid and reliable
approach in order to activate brain areas crucial for
emotion processing in general and crucial for the patho-
physiology of depression specifically [18]. Unsurpris-
ingly, emotional faces have been frequently employed in
neuroimaging studies in depressed patients, contributing
to the refinement of neurobiological models of depres-
sion [24-26]. Put simply, these models postulate
increased activity in brain regions essential for emo-
tional identification and production (that is, amygdala,
orbitofrontal cortex (OFC), striatum) and decreased
neural activity within regions important for emotion
regulation such as the dorsolateral prefrontal cortex
(DLPFC) and anterior cingulate cortex (ACC).
However, currently available data on emotional face
processing in depression are far from being consistent.
The heterogeneity of study samples (for example, state
of illness, medication status and so on), imaging para-
digms (for example, implicit or explicit processing para-
digms, stimulus material, baseline condition), and
analysis strategies (for example, activation or connectiv-
ity analyses) is reflected in apparently heterogeneous
and partly conflicting findings at first sight. Given the
importance of emotional face processing in major
depression, the goal of the present review is to provide a
comprehensive overview of neuroimaging studies inves-
tigating facial emotion processing in acutely depressed
patients compared with healthy controls. Particular
effort was made to delineate altered neural activation
patterns associated with mood-congruent processing
bias and to integrate these findings with functional con-
nectivity results.
First, we describe in detail the results of all available
fMRI studies comparing facial emotion-related brain
activation in patients with major depressive disorder
(MDD) and healthy control (HC) subjects. In addition
to whole brain and region of interest (ROI) data, recent
functional connectivity data will also be considered.
Figure 1 Emotional perception and processing stages.A f t e r
stimulus presentation (subliminal or supraliminal) the central
emotion perception and processing stages are: (1) the identification
and appraisal of stimulus significance, taking place with or without
conscious awareness; (2) the generation of an affective state,
expression of emotion and behavioral response; and (3) up or down
regulation (circles with positive/negative signs) of the affective state
and identification process. Modified from Phillips et al. [15].
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context of current models of depression and their possi-
ble role for ‘trait’ or ‘state’ aspects of depression.
Methods
To identify relevant functional neuroimaging studies
focusing on emotional face processing in major depres-
sion, a database search of journal articles via Medline,
Embase and Scopus was conducted from the year 2000
to August 2011. We used combinations of the keywords
‘fMRI’, ‘functional magnetic resonance’, ‘depression’,
‘MDD’, ‘face’, ‘facial expression’,a n d‘emotion’.A l ls t u -
dies were limited to English language publications. We
further examined the reference lists of review articles on
MDD and all studies identified for inclusion to check
for potentially useful studies not identified by computer-
ized literature search.
Studies were included if they: (1) were fMRI studies,
(2) statistically compared a group of adult patients with
MDD to a group of healthy volunteers (3) utilized facial
emotion expressions as stimuli (4) conducted a whole
brain analysis, ROI analysis or functional connectivity
analysis (5) reported results in acute depression (during
current episode). Thus, we did not consider results
reported in remitted patients. We did not include fMRI
studies simply correlating imaging data with clinical fea-
tures without any comparison to HCs.
Variables of interest extracted from the studies were
differences in neural activations during facial emotion
processing in MDD patients compared to HCs. There-
fore, we extracted the neuroimaging data of between-
group comparisons regarding experimental conditions
reflected by ‘emotion vs baseline’ contrasts (for example,
MDD > HC, HC > MDD).
Results
The literature search yielded a total of 25 studies meet-
ing the inclusion criteria (see Table 1). A total of 20 stu-
dies reported between-group results in terms of whole
brain and/or ROI data, whereas only 1 study found no
differences between MDD patients and the healthy con-
trol group at a pretreatment baseline [27]. Functional
connectivity data were reported by six studies. One
study reported both whole-brain and FC results [28].
Neurobiological differences in ‘activation’ by emotional
faces
Abnormal limbic activity
Amygdala Of the 20 included fMRI studies, 10 reported
significant differences in amygdala responsiveness in
M D Dp a t i e n t sc o m p a r e dt oH C sd u r i n ge x p o s u r et o
facial emotions. Two recent studies by Victor et al. [29]
and Suslow et al. [30], both using subliminal stimuli
presentation, reported a similar differential response
pattern of higher amygdala response to sad facial stimuli
and decreased responses to happy facial stimuli in MDD
patients compared to HCs. Related to negative stimuli,
supporting findings were reported earlier by Surguladze
et al. [31] and Fu et al. [32,33]; both groups observed
amygdala hyperactivation to overtly presented sad facial
expressions. In addition, increased amygdala activation
to fearful facial expressions was reported by Sheline et
al. [34]. The result of amygdala hyper-responsiveness to
sad/fearful faces (combined contrast) was again sup-
ported by Peluso et al. [35] and recently for fearful/
angry faces (combined contrast) by Zhong et al. [36].
Two results contradicting this pattern should also be
mentioned: first, decreased amygdala activation in
response to fearful faces in MDD patients compared to
HCs in a study investigating bipolar patients as a second
control group [37] and second, increased activation to
happy facial stimuli [34]. Finally, Matthews et al.[ 2 8 ]
described in a comparatively young patient sample with
early depression onset hyperactivation of the amygdala
in MDD patients versus HCs in a combined contrast
including fear, angry and happy faces.
In summary, half of the 20 relevant studies report
increased amygdala activation in response to emotional
faces in MDD patients compared to HCs. Across the
aforementioned studies, results indicate predominantly
hyper-responsiveness to negative facial expressions, in
particular to sadness. Avail a b l ed a t ao ns u b l i m i n a l
happy facial processing further suggests hyporesponsive-
ness of the amygdala in MDD patients.
Hippocampus Although several activations observed in
parts of the amygdala extended to (para)hippocampal
regions [33,37], only one activation peak has been
observed directly in the hippocampus [38]. The observed
result showed decreased hippocampus activity to sad
facial expressions in MDD patients.
Insula, parahippocampal gyrus/thalamus So far, only
one study by Surguladze et al. [39] investigated
responses to faces displaying different degrees of disgust
in MDD patients vs HCs. The authors observed greater
activation in the left insula in depressed patients com-
pared to HCs. Apart from altered processing of disgust
in MDD patients, additional altered activation to other
emotional faces has been reported in the insula: Suslow
et al. [30] demonstrated higher insula and parahippo-
campal gyrus (PHG) activation to sad faces and
decreased activation to happy faces. This was supported
by the results of earlier studies indicating the same
direction of insula and PHG responsiveness to sad and
happy stimuli, respectively. Zhong et al. [36] observed
increased insula activation to fearful/angry (combined
contrast) faces in a young sample of MDD patients.
Additionally, thalamic hyper-responsiveness to sad facial
stimuli has been reported by Fu et al. [32].
Stuhrmann et al. Biology of Mood & Anxiety Disorders 2011, 1:10
http://www.biolmoodanxietydisord.com/content/1/1/10
Page 3 of 17Table 1 Description of fMRI studies on facial emotion processing, comparing a group of major depressive disorder
(MDD) patients to healthy controls (HCs)
Author/year Reference Participants Patient
mean
age
(SD)
Patient (a)
mean
duration of
illness in
months; (b)
mean
episodes
Medication Emotions Paradigm and stimulus
type
Stimulus
duration
Analysis
approach
Whole brain and/or ROI data:
Almeida et al.
2010
[62] 15 MDD, 15
HC, (15
BDD), (15
BDDr)
32.74
(9.87)
(a) 13.67 ±
9.87;
(b) not
reported
Yes Fear, sad,
happy
Facial expression processing
paradigm. Ekman faces.
Morphed 50% and 100%
intensity. Explicit task: label
emotion.
2 s ROI
Frodl et al.
2009
[43] 12 MDD, 12
HC
43.3
(11.2)
Not reported Yes Sad,
angry
Emotion face-matching task.
Ekman faces. Explicit task:
match emotion. Implicit task:
match gender. Control task:
match shapes.
5.3 s Whole
brain, ROIs
Frodl et al.
2011
[27] 24 MDD, 15
HC
38.9
(10.4)
(a) 56.0 ±
63.4; (b) 1.6 ±
0.7
No Sad,
angry
Emotion face-matching task.
Faces from Gur and
colleagues. Explicit task:
match the emotion. Implicit
task: match the gender.
Control task: match shapes.
5.3 s Whole
brain
Fu et al. 2004;
Fu et al. 2007
[32,63] 19 MDD, 19
HC
43.2
(8.8)
Not reported No Sad,
happy
Facial expression processing
paradigm. Ekman faces.
Morphed to express low,
medium and high intensities.
Implicit task: indicate the sex
of the face.
3 s Whole
brain
Fu et al. 2008 [33] 16 MDD, 16
HC
40.0
(9.4)
(a) not
reported; (b)
0.63
No Sad Facial expression processing
paradigm. Ekman faces.
Morphed to express low,
medium and high intensities.
Implicit task: indicate the sex
of the face.
3 s Whole
brain
Gotlib et al.
2005
[45] 18 MDD, 18
HC
35.2 Not reported Yes Sad,
happy,
neutral
Facial expression processing
paradigm. Ekman faces.
Implicit task: indicate the sex
of the face.
3 s Whole
brain
Keedwell et
al. 2005
[42] 12 MDD, 12
HC
43 (9.8) Not reported Yes Sad,
happy,
neutral
Mood provocation paradigm.
Individual autobiographical
memory prompts played
prior to the presentation of
mood congruent facial
expressions. Ekman faces.
Task: oral subjective rating of
mood.
2 s Whole
brain
Lawrence et
al. 2004
[37] 9 MDD, 11
HC, (12
BDD)
41
a (11) (a) 96 ± 60;
(b) not
reported
Yes Sad, fear,
happy,
neutral
Facial expression processing
paradigm. Ekman faces.
Morphed 50% and 100%
intensity. Implicit task:
indicate the sex of the face.
2 s Whole
brain, ROIs
Lee et al.
2008
[38] 21 MDD, 15
HC
46.8
(9.1)
(a) 14.8 ± 3.3;
(b) 1.9 ± 0.8
Yes Sad,
angry,
neutral
Face viewing paradigm. Data
set of Korean faces. Task:
evaluative ratings (arousal,
valence).
1.5 s ROIs
Matthews et
al. 2008
[28] 15 MDD, 16
HC
24.5
(5.5)
(a) not
reported; (b)
4.46
No Angry,
fear,
happy
Emotion face-matching task.
Emotional faces. Task: match
faces.
5 s ROI
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(MDD) patients to healthy controls (HCs) (Continued)
Peluso et al.
2009
[35] 14 MDD, 15
HC
37.9
(14)
Not reported No Angry,
fear
Emotion face-matching task.
Ekman faces. Explicit task:
match emotion. Implicit task:
match faces. Control task:
match shapes.
5 s Whole
brain, ROI
Scheuerecker
et al. 2010
[41] 13 MDD, 15
HC
37.9
(10.1)
(a) 52.3 ±
71.5; (b) 1.45
± 0.68
No Sad,
angry
Emotion face-matching task.
Faces from Gur and
colleagues. Explicit task:
match the emotion. Implicit
task: match the gender.
Control task: match shapes.
Whole
brain
Sheline et al.
2001
[34] 11 MDD, 11
HC
40.3 Not reported No Fear,
happy,
neutral
Subliminal emotion
paradigm. Masked Ekman
faces. Task: indicate the sex
of the face.
Prime: 40
ms; mask:
160 ms
ROI
Surguladze et
al. 2010
[39] 9 MDD, 9
HC
42.8
(7.2)
(a) 96 ± 61.2;
(b) not
reported
Yes Disgust,
fear,
neutral
Facial expression processing
paradigm. Ekman faces.
Morphed 50% and 100%
intensity. Implicit task:
indicate the sex of the face
+ offline facial affect
recognition task.
2 s Whole
brain
Surguladze et
al. 2005
[31] 16 MDD, 14
HC
42.3
(8.4)
(a) 90 ± 61.2;
(b) not
reported
Unknown Sad,
happy,
neutral
Facial expression processing
paradigm. Ekman faces.
Morphed 50% and 100%
intensity. Implicit task:
indicate the sex of the face.
2 s Whole
brain, ROIs
Suslow et al.
2010
[30] 30 MDD, 26
HC
38.8
(11.4)
(a) 72.2 ±
75.0; (b) 2.7 ±
2.0
Yes Sad,
happy,
neutral
Subliminal emotion
paradigm. Masked Ekman
faces. Task: evaluative ratings
of the neutral mask face
(valence) + offline detection
task.
Prime: 33
ms; mask:
467 ms
Whole
brain, ROI
Townsend et
al. 2010
[40] 15 MDD, 15
HC
46.6
(11.2)
(a) 176.4 ±
159.6;
(b) 3
(median)
No Sad,
fearful
Emotion face-matching task.
Ekman faces. Explicit task:
match emotion. Control task:
match shapes.
Whole
brain, ROIs
Victor et al.
2010
[29] 22 MDD (16
MDDr), 25
HC
33.2
(5.0)
Not reported No Sad,
happy,
neutral
Subliminal emotion
paradigm. NimStim set of
facial expressions. Task:
remember the neutral target
face and respond to indicate
whether this target face
appears during the current
trial.
Prime: 26
ms; mask:
107 ms
Whole
brain, ROI
Zhong et al.
2011
[36] 29 MDD, 31
HC, (26 CV
subjects)
20.45
(1.82)
Not reported No Fearful,
angry
Emotion face-matching task.
Standardized set of Chinese
facial expressions. Implicit
task: match faces. Control
task: match shapes.
5 s ROI, Whole
brain
Functional connectivity studies:
Almeida et al.
2009
[47] 16 MDD, 16
HC, (15
BDD)
32.3
(9.7)
(a) 13.4 ± 9.6;
(b) not
reported
Yes Sad,
happy,
neutral
Facial expression processing
paradigm. Ekman faces.
Morphed 50% and 100%
intensity. Explicit task: label
emotion.
2 s Dynamic
causal
modeling
Carballedo et
al. 2011
[48] 15 MDD, 15
HC
39.87
(8.57)
Not reported No Sad,
angry
Emotion face-matching task.
Ekman faces. Explicit task:
match emotion. Control task:
match shapes.
5.25 s Structural
equation
modeling
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between the insula, PHG area and amygdala, supporting
the hypothesis of an emotion bias in limbic structures in
MDD patients, with hyper-responsiveness to negative
facial expressions and hyporesponsiveness to happy
facial expressions. Nevertheless, one group detected
decreased activity in the insula in a combined contrast
of sad and fear [40] which differs from this pattern.
Striatum Aberrant activity in striatal structures also
resembles the activation pattern observed in the amyg-
dala and insula. Again, predominant putamen/caudate
nucleus hyper-responsiveness to sad/angry facial expres-
sions and rather hyporesponsiveness in response to
happy facial expressions has been observed [32,33,37,41].
Abnormal frontal activity
Motor cortex and prefrontal cortex Initially, there is
good agreement among the results reported for the
motor cortex, a brain area that has been given little
attention in emotion processing. Hyperactivated motor
cortex (Brodmann’s area (BA) 6, BA 4) during sad and
angry facial processing in MDD patients compared to
HCs was reported by four studies [32,33,41,42]. Findings
in the lateral prefrontal cortex (PFC) are less consistent:
comparing aberrant increased to decreased activation to
sad and angry facial stimuli in DLPFC in MDD patients,
we find both reported nearly equally often
[30,36,37,42,43]. Similar inconsistencies were reported
regarding neural responsiveness to happy facial stimuli
in DLPFC and in more ventral, lateral PFC areas (see
Table 2 for details). Even though altered neuronal
responses in DLPFC are a prevalent finding in MDD
patients, it is hardly possible to draw a final conclusion
about a general hyper/hypoactivation of the DLPFC
during facial emotion processing in unipolar depression,
underlining the variability in neuroimaging results. In
OFC several independent studies detected decreased
activation in inferior and medial OFC areas in response
to either sad, fear or angry facial stimuli [37,38,42].
Furthermore, Surguladze et al. [39] reported hyperacti-
vation to disgust in OFC in MDD patients.
Cingulate gyrus Aberrant activation in the posterior,
mid and anterior cingulum in MDD patients compared
to HCs has been almost solely reported to facial expres-
sions of sadness.
Findings in posterior cingulate responsiveness are con-
tradictory: Fu et al. [32] and Keedwell et al. [42] reported
enhanced activity in the posterior cingulum, whereas in a
later therapy study by Fu and colleagues [33] weakened
activity in MDD patients compared to HCs in closely
related areas emerged. In the middle cingulate gyrus, two
independent studies point to rather enhanced neural
responses to sad/angry facial stimuli in MDD patients
compared to HCs [32,43]. Of particular concern in the
pathophysiology of affective disorders is the role of the
ACC [23,44]. Decreased responses to sad facial stimuli in
MDD patients compared to HCs in dorsal parts of the
ACC were reported by Lawrence et al. [37] and Fu et al.
[33]. However, one study revealed a contradictory finding
of rather increased responsiveness in dorsal ACC to sad
facial expressions [32]. Interestingly, Gotlib et al. [45]
reported two hyperactivated clusters in different subgen-
ual parts of the ACC in the MDD group to sad and
happy facial expressions, respectively. Figure 2 presents a
summary of altered activation loci for facial emotion pro-
cessing tasks within the posterior, middle and anterior
cingulum in unipolar depression.
Table 1 Description of fMRI studies on facial emotion processing, comparing a group of major depressive disorder
(MDD) patients to healthy controls (HCs) (Continued)
Chen et al.
2008
[49] 19 MDD, 19
HC
34.3
(8.6)
Not reported No Sad Facial expression processing
paradigm. Ekman faces.
Morphed to express low,
medium and high intensities.
Implicit task: indicate the sex
of the face.
3 s Functional
connectivity
Dannlowski
et al. 2009
[50] 34 MDD, 31
HC
38.6
(12.2)
(a) 125.0 ±
125.5; (b) 4.7
± 5.3
Yes Sad,
angry,
happy,
neutral
Passive face viewing
paradigm. Ekman faces.
500 ms Functional
connectivity
Frodl et al.
2010
[51] 25 MDD, 15
HC
39.4
(10.4)
(a) 51.8 ±
63.9; (b) 1.52
± 0.6
No Sad,
angry
Emotion face-matching task.
Ekman faces. Explicit task:
match emotion. Implicit task:
match gender. Control task:
match shapes.
Functional
connectivity
Mathews et
al. 2008
[28] 15 MDD, 16
HC
24.5
(5.5)
(a) not
reported; (b)
4.46
No Angry,
fear,
happy
Emotion face-matching task.
Emotional faces. Task: match
faces.
5 s Functional
connectivity
BDD, bipolar disorder; BDDr, bipolar disorder remitted; CV, cognitive vulnerability; MDDr, major depressive disorder remitted; ROI, region of interest
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controls (HCs))
Brain region BA Sad >
Baseline
Fear >
Baseline
Angry >
Baseline
Happy >
Baseline
Disgust >
Baseline
Author/year Reference
Limbic lobe
Amygdala ↑ Fu et al. 2004 [32]
Amygdala ↑↑ Peluso et al. 2009 [35]
Amygdala ↑
a ↑
a Sheline et al. 2001 [34]
Amygdala ↑↓ Suslow et al. 2010 [30]
Amygdala ↑↓ Victor et al. 2010 [29]
Amygdala ↑↑ Zhong et al. 2011 [36]
Extended amygdala ↑↑ ↑ Matthews et al. 2008 [28]
Amygdala/hippocampus ↑ Fu et al. 2008 [33]
PHG/amygdala ↑
b Surguladze et al. 2005 [31]
Amygdala/hippocampus ↓ Lawrence et al. 2004 [37]
Hippocampus ↓ Lee et al. 2008 [38]
Extended limbic system
Insula ↑ Fu et al. 2004 [32]
Insula 13 ↓ Gotlib et al. 2005 [45]
Insula ↑ Keedwell et al. 2005 [42]
Insula ↑ Surguladze et al. 2010 [39]
Insula 13 ↑↑ Zhong et al. 2011 [36]
Insula ↓↓ Townsend et al. 2010 [40]
Insula/PHG ↑↓ Suslow et al. 2010 [30]
PHG ↑ Fu et al. 2008 [33]
PHG/globus pallidus/anterior
thalamus
↓↓ Lawrence et al. 2004 [37]
Thalamus ↑ Fu et al. 2004 [32]
Striatum
Putamen ↑ Fu et al. 2008 [33]
Putamen ↑
b ↓
b Surguladze et al. 2005 [31]
Putamen ↓↓ Townsend et al. 2010 [40]
Putamen/globus pallidus ↑ Fu et al. 2004 [32]
Uncus/amygdala/caudate/
putamen
↓ Lawrence et al. 2004 [37]
Caudate ↑ Fu et al. 2004 [32]
Caudate ↓ Lee et al. 2008 [38]
Caudate ↑↑ Scheuerecker et al. 2010 [41]
Frontal lobe
Motor cortex
Premotor cortex 6 ↑ Fu et al. 2004 [32]
Middle frontal gyrus 6 ↑ Fu et al. 2008 [33]
SMA ↑↑ Scheuerecker et al. 2010 [41]
Precentral gyrus 4 ↑ Fu et al. 2004 [32]
Precentral gyrus 4 ↑ Fu et al. 2008 [33]
Precentral gyrus 4 ↑ Keedwell et al. 2005 [42]
Precentral gyrus 4,6 ↓ Keedwell et al. 2005 [42]
Precentral gyrus ↑↑ Scheuerecker et al. 2010 [41]
Postcentral gyrus 1, 2, 3 ↑ Fu et al. 2004 [32]
Postcentral gyrus ↑↑ Frodl et al. 2009 [43]
Postcentral gyrus 2 ↑ Keedwell et al. 2005 [42]
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controls (HCs)) (Continued)
DLPFC
DLPFC 44, 45, 9 ↓↓ ↓ Lawrence et al. 2004 [37]
DLPFC 9 ↑ Keedwell et al. 2005 [42]
Superior frontal gyrus ↑
a ↑ Frodl et al. 2009 [43]
Superior frontal gyrus 8 ↑ Gotlib et al. 2005 [45]
Superior frontal gyrus 8 ↓ Fu et al. 2008 [33]
Superior frontal gyrus 8 ↓↓ Zhong et al. 2011 [36]
Middle frontal gyrus ↑
a ↑ Frodl et al. 2009 [43]
Middle frontal gyrus ↑↓ Suslow et al. 2010 [30]
Middle frontal gyrus 8 ↓ Fu et al. 2008 [33]
Middle frontal gyrus 8 ↓ Keedwell et al. 2005 [42]
VLPFC
VLPFC 10, 47,
45, 46
↓ Lawrence et al. 2004 [37]
VLPFC 11 ↑ Gotlib et al. 2005 [45]
VLPFC 10/47 ↓ Keedwell et al. 2005 [42]
Middle frontal gyrus 10/47 ↑ Keedwell et al. 2005 [42]
Middle frontal gyrus ↑↑ Scheuerecker et al. 2010 [41]
Cingulum
Anterior cingulum 32 ↑ Fu et al. 2004 [32]
Anterior cingulum 24/32 ↓ Fu et al. 2008 [33]
Anterior cingulum 25 ↓↓ Zhong et al. 2011 [36]
Sg anterior cingulum 25 ↑ Gotlib et al. 2005 [45]
Sg anterior cingulum 24/32 ↑
a Gotlib et al. 2005 [45]
Anterior cingulum 24 ↓ Lawrence et al. 2004 [37]
Middle cingulum 23/24 ↑ Fu et al. 2004 [32]
Middle cingulum 33/24,
32/24
↓ Fu et al. 2008 [33]
Middle cingulum ↑
a ↑ Frodl et al. 2009 [43]
Middle cingulum 23 ↑ Keedwell et al. 2005 [42]
Posterior cingulum 23/31,
29/31
↑ Fu et al. 2004 [32]
Posterior cingulum 31 ↓ Fu et al. 2008 [33]
Posterior cingulum 31 ↓ Fu et al. 2007 [63]
Posterior cingulum 31 ↑ Keedwell et al. 2005 [42]
Medial PFC
Inferior frontal gyrus 47 ↑ Gotlib et al. 2005 [45]
Inferior frontal gyrus 47/45 ↓ Gotlib et al. 2005 [45]
Inferior frontal gyrus 45 ↑ Keedwell et al. 2005 [42]
Inferior frontal gyrus 47 ↓↓ Zhong et al. 2011 [36]
Medial PFC 10, 11,
47
↓ Lawrence et al. 2004 [37]
DMPFC 8 ↑ Keedwell et al. 2005 [42]
VMPFC 10/32 ↑ Keedwell et al. 2005 [42]
Orbitofrontal cortex
Orbitofrontal cortex 47 ↑ Surguladze et al. 2010 [39]
Orbitofrontal cortex 11 ↓ Lawrence et al. 2004 [37]
Orbitofrontal cortex 11 ↓ Keedwell et al. 2005 [42]
Orbitofrontal cortex ↓↓ Lee et al. 2008 [38]
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Lateral: middle temporal gyrus (MTG: BA 21), infer-
ior temporal gyrus (ITG: BA 20), superior temporal
gyrus (STG: BA 22, 42) In MDD patients, several
hyperactivations in MTG, ITG and STG in response to
sad facial stimuli have been detected [30,33,42], contrary
to two observed hypoactivated clusters. In addition,
noticeable deactivation to happy facial expressions sti-
muli has been observed, too [40,45]. Specific to the
emotion of disgust, Surguladze et al. [39] described
increased activation in MTG and STG in MDD patients.
Medial: fusiform gyrus/fusiform face area (BA 37)
Suslow et al.[ 3 0 ]a n dS u r g u l a d z eet al. [31] both
reported a pattern of increased activation to sad facial
expression and decreased activation to happy facial
expression in fusiform gyrus in MDD patients compared
to HCs. One study supported this pattern [42], also
observing increased activation to sad facial stimuli,
whereas a deactivation in fusiform gyrus during sad
facial processing has also been detected [33].
Differential effects of valence (positive versus negative
facial emotions)
In limbic regions, the combined results of aberrant
negative face processing in MDD patients revealed pre-
dominantly exaggerated responsiveness of the
amygdala, PHG and insula (for details, see section
above). In striatal regions, further increased respon-
siveness to negative stimuli has been detected in puta-
men and caudate nucleus [31-33,41]. By contrast, data
on the processing of positive facial stimuli rather indi-
cate decreased responsiveness in MDD patients com-
pared to HCs in the amygdala, insula, PHG and
putamen [29-31,37,45]. In frontal lobe structures a
deviant neural response picture emerged: exaggerated
responses to negative facial stimuli in MDD patients
occurred particularly in the motor cortex [32,33,41,42]
and in the middle and subgenual cingulum (see Figure
2), whereas rather decreased responsiveness was domi-
nant in the OFC [37,38,42]. Concerning the processing
of positive facial stimuli in frontal areas, increased as
well as decreased activity has been observed in MDD
patients (see Table 2). Thus, the present data suggest
group × valence interactions particularly in areas
involved in the generation of affective responses, indi-
cating a neurobiological substrate of mood-congruent
processing bias. However, unfortunately only a few stu-
dies explicitly investigated group × valence interactions
in factorial designs. Brain areas showing group ×
valence interactions include the amygdala [29,30],
insula, PHG [30], the fusiform gyrus [30,31] and puta-
men [31].
Table 2 Emotional face processing studies: between group fMRI findings (major depressive disorder (MDD) > healthy
controls (HCs)) (Continued)
Orbitofrontal cortex ↓↓ Lee et al. 2008 [38]
Temporal lobe
Middle temporal gyrus 21 ↓ Gotlib et al. 2005 [45]
Middle temporal gyrus 21/22 ↓ Keedwell et al. 2005 [42]
Middle temporal gyrus 21 ↑ Surguladze et al. 2010 [39]
Middle temporal gyrus ↑↓ Suslow et al. 2010 [30]
Middle temporal gyrus/inferior
temporal gyrus
↑↓ Suslow et al. 2010 [30]
Middle temporal gyrus 21, 37 ↓ Townsend et al. 2010 [40]
Inferior temporal gyrus 20 ↓ Gotlib et al. 2005 [45]
Inferior temporal gyrus 37 ↑ Surguladze et al. 2010 [39]
Inferior temporal gyrus 20 ↓ Townsend et al. 2010 [40]
Superior temporal gyrus 42 ↑ Fu et al. 2008 [33]
Superior temporal gyrus 42 ↑ Keedwell et al. 2005 [42]
Fusiform gyrus 37 ↓ Fu et al. 2008 [33]
Fusiform gyrus 20 ↑ Keedwell et al. 2005 [42]
Fusiform gyrus 19 ↑
b ↓
b Surguladze et al. 2005 [31]
Fusiform gyrus ↑↓ Suslow et al. 2010 [30]
The table includes whole brain and region of interest (ROI) results of the described studies in Table 1, section ‘Whole Brain and ROI studies’. The table does not
include results on other study aspects such as treatment response or connectivity analyses.
aDue to deactivations in controls.
bLinear trend for increasing intensities of sadness/happiness.
BA, Brodmann’s area; DLPFC, dorsolateral prefrontal cortex; DMPFC, dorsomedial prefrontal cortex; PFC, prefrontal cortex; PHG, parahippocampal gyrus; SMA,
supplementary motor area; Sg, subgenual; VLPFC, ventrolateral prefrontal cortex; VMPFC, ventromedial prefrontal cortex.
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Connectivity analysis in functional neuroimaging can be
subdivided into two general classes: functional connec-
tivity (FC), which examines simple correlations between
neural activity in two anatomically distinct brain areas;
and effective connectivity (EC), which measures the
directional influence that one neural system exerts over
another [46]. The most influential models of depressive
disorders assume that depressive symptoms might rather
result from abnormal interactions between several brain
regions than from differences in single (isolated) local
brain function [7,23,25]. However, relatively few func-
tional neuroimaging studies have investigated connectiv-
ity within these postulated networks. To date, six
studies have examined neural connectivity in MDD
patients compared to HCs during the processing of
facial expressions [28,47-51]. One of the first studies by
Chen et al. [49] in 19 unmedicated patients with MDD
and 19 HCs used regression analysis between the amyg-
dala and all other brain regions on neural activity to sad
facial expressions. The authors found decreased FC of
bilateral amygdala in depressed patients compared to
matched HCs in the hippocampus, putamen, insula,
PHG, inferior, middle, and superior temporal cortices,
and inferior/middle frontal cortices before antidepres-
sant treatment. Antidepressant treatment was associated
with a significant increase in FC between the amygdala
and right frontal cortex, supragenual ACC, striatum and
thalamus in MDD subjects. Matthews et al. [28] focused
explicitly on differences in amygdala-cingulate FC dur-
ing emotional face processing in 15 MDD patients and
16 HCs. The results indicate increased FC between the
bilateral amygdala and subgenual ACC and decreased
FC between the amygdala and supragenual ACC in
MDD patients. Furthermore, greater depressive symp-
tom severity was positively correlated with decreased
coactivation of the supragenual cingulate in MDD sub-
jects. Dannlowski et al. [50] calculated FC of the amyg-
dala with prefrontal areas based on neural activity
during passive viewing of negative emotional faces in a
large sample of 34 MDD patients with relatively long ill-
ness history and 32 HC subjects. Depressed patients
showed significantly reduced connectivity of the amyg-
dala with the dorsal ACC and DLPFC. Taken together,
all three FC studies show comparable results concerning
abnormally reduced FC between the amygdala and dor-
sal/supragenual ACC regions in acute depression, while
amygdala-subgenual ACC connectivity seems to be
increased. Recently, Frodl et al. [51] selected the OFC
instead of the amygdala as the ‘seed region’ for func-
tional connectivity analysis. In 15 unmedicated MDD
patients and 15 HC subjects, functional connectivity
between the OFC and other brain regions was assessed
during negative facial emotion processing. Results
between patients and HCs demonstrate that the OFC
coactivated less with the dorsal ACC, precuneus, and
cerebellum and more with the right DLPFC, right infer-
ior frontal operculum, and left motor areas in the
patient group.
To the best of our knowledge, facial emotion proces-
sing in MDD patients has only twice been investigated
with effective connectivity techniques. Almeida et al.
[47] used dynamic causal modeling (DCM) to examine
EC between the amygdala and medial OFC. Their data
showed reduced left-sided top-down OFC-amygdala EC
in the happy and sad facial processing paradigm in a
sample of predominantly female depressed subjects
compared to HCs. Recently, Carballedo et al. [48] used
structural equation modeling (SEM) to calculate the dif-
ferences in effective connectivity between 15 MDD
patients and 15 HCs. The authors proposed an emo-
tional model including the amygdala, OFC, ACC and
PFC. Bilaterally, the path analysis revealed attenuated
connectivity strengths from the amygdala to OFC during
sad and angry facial processing in patients compared to
controls. Additionally, for the right hemisphere, patients
show lower connectivity from the amygdala to the ACC
and from ACC to PFC, whereas controls show lower
connectivity in the opposite direction, namely from
ACC to the amygdala. One should note that both EC
studies reviewed here found lower left-sided influences
between the amygdala and OFC, although the study by
Figure 2 Increased and decreased cingulate activation in major
depressive disorder (MDD) patients in emotional face
processing studies. Paramedian slice of a Montreal Neurological
Institute (MNI) template depicting abnormal cingulate activation
during emotional face processing in major depressive disorder. Peak
activation coordinates reported by primary authors in Talairach
coordinates were converted into MNI space. Light blue:
hyperactivation, dark blue: hypoactivation. ACC = anterior cingulate
cortex.
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one by Carballedo et al. [48] bottom-up alterations.
In summary, functional connectivity between the
amygdala and other brain areas shows (a) decreased
amygdala coupling with other limbic regions (hippocam-
pus, putamen, insula, PHG), temporal regions, and in
particular with the supragenual/dorsal ACC and DLPFC,
and (b) increased coupling with subgenual ACC. Of par-
ticular concern seems to be the role of the ACC, resem-
bling results identified with conventional fMRI analysis.
T h el o n g i t u d i n a ld a t ab yC h e net al. [49] provide first
evidence that decreased FC coupling between the amyg-
dala and supragenual ACC increases after pharmacologi-
cal intervention.
Discussion
The present review aimed to summarize available
empirical data regarding the neural correlates of abnor-
mal emotional face processing in acute unipolar depres-
sion (during the current episode). Presenting differential
facial expressions activates a common face-processing
network in HCs and MDD patients, including primary
visual pathways as well as further supporting brain areas
crucial for emotion processing in general. The amygdala
belongs to the latter group, t h ee x t e n d e dl i m b i cs y s t e m
and specific frontal areas, namely the ACC, OFC and
ventromedial prefrontal cortex (VMPFC). These regions
are of particular interest for understanding the patho-
physiology of unipolar depression. Our analysis indicates
evidence of abnormal neural face processing in MDD
patients, especially in the amygdala, the insula, PHG,
ACC and OFC. Although neural alterations were
reported in several other brain regions, the Discussion
section focuses on these areas because they are (a) cru-
cial for evaluating the neural mood-congruent face pro-
cessing hypothesis, and (b) are core domains in an
altered functional connectivity network in MDD patients
during emotional face processing.
Neural mood-congruent face processing
Neural responses in MDD patients associated with
mood-congruent processing patterns are most evident in
the amygdala [29,30], insula and PHG [30], the fusiform
gyrus [30,31] and putamen [31].
The amygdala plays a pivotal role in emotion proces-
sing and in the perception and processing of emotional
salience in facial expressions (for reviews see [52-54]).
Furthermore, the amygdala is a key region within the
neurobiological framework of depressive disorder. Sev-
eral authors have suggested that, for MDD, mood-con-
gruent bias in behavioral measures is strongly linked to
amygdala hyper-responsiveness to negative stimuli
[2,55,56]. Findings of increased amygdala responsiveness
to negative emotional faces are well in line with several
imaging studies employing other stimuli, including nega-
tive words [57,58], individualized self-referential sen-
tences [59], or in expectation of negative pictures [60].
Furthermore, these findings are supported by studies in
depressed adolescents [61].
However, not all fMRI studies have found evidence for
altered amygdala activation in MDD. In detail, 10 of the
20 included studies reported differences in amygdala
activation between MDD patients and HCs using face
emotion processing tasks [28-37], while the other stu-
dies found no significant group effects
[27,38-43,45,62,63]. Nevertheless, focusing on the
observed differences in amygdala responsiveness, studies
provide compelling support for amygdala mood-congru-
ent processing in MDD patients. First, abnormal amyg-
dala responsiveness has been shown to negative and
positive facial expressions, corroborating amygdala func-
tion in processing salient stimuli, independent of stimuli
valence [64]. Second, as hypothesized in mood congru-
ent processing theories of depression, the majority of
results show exaggerated amygdala response to sad sti-
muli, and in addition decreased amygdala response to
happy facial stimuli, although replications with happy
facial expressions are still rare. These results indicate
that, in convergence with behavioral measures, neuro-
biological assessment can be a sensitive measure for
mood-congruent biases in unipolar depression. Of note
are two recent studies using subliminal presentation
conditions pointing to mood congruency effects to nega-
tive and positive stimuli already at early, automatic pro-
cessing stages [29,30].
In conclusion, the findings of our analysis support the
assumption that amygdala hyperactivity is associated
with negatively biased facial emotion processing impli-
cated in the pathophysiology of major depression,
although this became evident in only one-half of the
reviewed studies. Studies investigating the question of
whether abnormalities in amygdala responses to emo-
tional faces demonstrated in acute depression represent
a state marker of acute depressive episodes or vulner-
ability factors for depression are rare. In remitted
patients, Neumeister et al. [65] demonstrated enhanced
regional cerebral blood flow responses to sad facial
expressions in the amygdala relative to HCs, but others
have failed to replicate these findings in remitted
patients [66,67]. In people at risk for depression, van der
Veen et al. [68] and Monk et al. [69] reported greater
abnormal amygdala activation to negative facial expres-
sion, but again inconsistent findings exist [70]. Interest-
ingly, Zhong et al. [36] reported higher amygdala
activation evident in both MDD subjects and a sample
of healthy people with high cognitive vulnerability to
depression compared to HCs. Increased left amygdala
responsiveness was positively associated with CSQ
Stuhrmann et al. Biology of Mood & Anxiety Disorders 2011, 1:10
http://www.biolmoodanxietydisord.com/content/1/1/10
Page 11 of 17scores (measures causal attributions, consequences and
self-worth characteristics). In addition, Cremers et al.
[71] reported that right amygdala-dorsomedial PFC con-
nectivity for negative faces vs neutral faces was posi-
tively associated with neuroticism scores, a personality
trait related to the development of affective disorders.
Finally, a recent study by Dannlowski et al. [72] investi-
gated long-term effects of childhood maltreatment with
fMRI in psychologically healthy participants. The
observed association between childhood maltreatment
and amygdala responsiveness during emotional face pro-
cessing resembles findings in depressed patients, sug-
gesting that these functional changes might constitute a
predisposition for developing affective disorders.
Hyperactivated amygdala to negative emotional faces
in remitted patients and people at high risk for depres-
sion is indicative of trait vulnerability. This interpreta-
tion receives support from imaging genetics and twin
studies, suggesting that amygdala responsiveness to
emotional faces as well as amygdala prefrontal connec-
tivity are under strong genetic influence [73-78].
Some methodological aspects explaining the heteroge-
neity of studies should be discussed here. With regard
to presentation modus, all three studies using subliminal
presentation of facial expressions reported differences in
amygdala activation [29,30,34]. Victor et al.[ 2 9 ]e v e n
observed differences in amygdala activation specific to
masked presentation of sad and happy faces, absent to
unmasked stimuli, supporting the assumption that sub-
liminal stimuli presentation maybe an advantage in
identifying emotional-processing biases in MDD with
focus on amygdala activation. It may be subliminal sti-
mulus presentation prevents confounding with other
cognitive processes prevalent in depression such as
rumination on negative thoughts/preservation of atten-
tion to negative faces [34]. Comparing paradigms pre-
senting facial stimuli supraliminally, only about half of
the investigations implementing either face-matching
paradigms or the ‘face recognition task’ observed amyg-
dala differences. Scheuerecker et al. [41] suggested that
participants probably used more visual and cognitive
strategies to solve the face-matching task, causing ACC
and PFC activation maybe inhibiting amygdala activa-
tion. Concerning task type (that is, explicit or implicit),
an implicit task, requiring participants to focus on gen-
der aspects of the face, seems to be sufficient to elicit
amygdala activation [28,31-33,35,36]. As amygdala and
frontal responsiveness depends on task complexity, face
type and attention focus, future research should take
into account such variations in designing facial proces-
sing paradigms.
Furthermore, medication status has an important
impact on neural activation patterns: seven of the ten
studies reporting altered amygdala activation were
performed on unmedicated patients. This result is not
surprising regarding the converging evidence, that amyg-
dala is a key region for antidepressant effects, reducing
abnormal amygdala responsiveness to negatively
valenced faces in MDD patients (for a recent meta-ana-
lysis see [79]). Other possible influencing factors may be
methodological aspects such as experimental design (for
example, event-related vs block design) or the selection
of different baseline conditions (for example, neutral
faces or a no-face condition) as well as clinical and non-
diagnostic variables such as age, comorbidity, treatment
history and number of prior episodes (for details see
Table 1). Furthermore, difficulties in detecting altered
amygdala responsiveness in MDD patients may be
caused by a ‘ceiling’ effect. As noted by Townsend et al.
[40], several PET studies have shown increased resting
blood flow in the amygdala in MDD patients [80-84],
making it difficult to detect group differences in activa-
tion tasks if amygdala baseline activation was already
increased.
Aside from the amygdala, several other subcortical
brain structures show activation patterns supporting
mood-congruent processing in depressed patients. Insula
hyperactivation to sad facial stimuli is a prominent
result, and furthermore two independent studies
observed hypoactivation to happy facial stimuli (see
Table 2). Apart from having a pivotal role in the proces-
sing of disgust [39] the insula has strong functional con-
nections to the amygdala [85]. Insula projections to
inferior parietal cortex and the amygdala are involved in
identifying/representing motivational salient informa-
tion, social cues and the expression of conditioned
responses: particularly on implicit processing pathways
[86,87]. Furthermore, activity in the putamen and cau-
date nucleus also resembles mood-congruent activation
patterns in MDD patients, although contributions to the
processing of facial expressions are still under debate
[87]. In visual face areas, fusiform gyrus responsiveness
also indicates mood-congruent processing in terms of
increased activation to sad facial expressions and
decreased activation to happy faces. In addition to
encoding face traits and facial identity [20], recent stu-
dies revealed that fusiform regions are also sensitive to
facial emotional expression (for a review see [88]). The
authors suggest that the modulation by emotional effects
can be explained by direct connections between visual
cortex and the amygdala, facilitating direct feedback sig-
nals from the amygdala [89] to visual processing areas.
In summary, neuronal correlates of mood-congruent
facial affect processing in MDD patients are most pro-
minent in limbic and subcortical regions, compromising
the amygdala, insula and putamen/caudate nucleus. In a
larger context these regions are hypothesized to be part
of an extended emotional face processing system [20]
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cognition processing, appraising emotional behavior and
producing affective states, altered in unipolar depression
[25]. As described, these alterations may even influence
visual processing areas such as the fusiform face gyrus.
Studies in remitted patients and in people at risk for
depression provide the first indications that enhanced
limbic neural responses to negative emotional material
may contribute to vulnerability to MDD [65,68,69].
Abnormal ACC and OFC activity
The analysis of whole-brain and functional connectivity
data highlight two more regions showing abnormal acti-
vation patterns during emotional face processing in
MDD: the cingulate gyrus and the orbitofrontal cortex.
Findings in the cingulate gyrus derived by our whole-
brain and ROI analysis (see Figure 2) can be broadly
subsumed by hyperactivated posterior/middle cingulum,
hypoactivated dorsal anterior cingulum and hyperacti-
vated ventral/subgenual anterior cingulum in MDD
patients compared to HCs, although findings are less
clear for different subregions of the ACC than expected.
Several authors postulate a central role particularly for
the ACC in the neurobiology of depression, with a spe-
cial role in therapy response [90-92]. The ACC plays a
crucial role for attentional processes that integrate cog-
nitive and emotional processes. While the subgenual
ACC seems to be involved in the generation and recog-
nition of emotional states, the supragenual/dorsal ACC
seems to be crucial for emotion regulation [25,93,94].
Functional connectivity results between amygdala and
subgenual/supragenual ACC on emotional face proces-
sing extend the above described neural activation pat-
tern: while (hypoactivated) dorsal regions of the ACC
show decreased FC with the amygdala, the rather hyper-
activated subgenual parts seem to have increased con-
nectivity with the amygdala ([28,49,50]; see Figure 3).
On the one hand, cognitive parts of the ACC are less
activated in MDD patients compared to HCs during
emotional face processing and show decreased FC to the
amygdala, suggesting less capability in MDD patients to
modify/suppress emotional salient information crucial
for patients’ affective states and behavioral responses.
On the other hand, connections between subgenual
parts of the ACC and the amygdala are increased,
maybe mutually enhancing abnormal emotion proces-
sing. Future studies should address the direction of
influence between different parts of the ACC and the
amygdala in more detail, preferably using EC methods
and more refined models. A recent example is the EC
s t u d yb yC a r b a l l e d oet al. [48], pointing to lower con-
nectivity strength from the amygdala to the ACC in
patients.
Moreover, results on medication effects concerning
abnormal ACC activity should also be taken into
account and can extend the interpretations. Antidepres-
sant medication reduced ACC activity in HCs during an
emotion provoking paradigm [95] and Pizzagalli recently
highlighted in his meta-analysis that increased rostral
ACC activity at rest is a strong marker of treatment
response in depression [96]. Because these data are
mainly derived from acutely depressed patients, it is still
unknown whether abnormal ACC responses represent
state markers of depression or a vulnerability factor
[96]. The first evidence supporting the latter notion
comes from the previously mentioned study by Cremers
et al. [71]. The authors reported a negative correlation
between amygdala-ACC connectivity and neuroticism to
negative faces compared to neutral faces, possibly indi-
cating that highly neurotic patients are characterized by
less inhibitory control of the ACC over the amygdala,
which may reflect vulnerability for MDD. A second
study in young people at risk for depression would sup-
port a possible diminished cortical regulation of negative
emotional faces [70].
With respect to the OFC, whole-brain and ROI ana-
lyses display remarkably decreased neural activity in
MDD patients compared to HCs in medial OFC areas
to negative facial stimuli [37,38,42]. In addition, FC
between the OFC and other brain areas revealed
Figure 3 Schematic illustration of main results reported in fMRI
connectivity studies on aberrant emotional face processing in
major depressive disorder (MDD) patients. Double arrows
represent results derived by functional connectivity approaches,
whereas the normal arrows present the result derived by effective
connectivity analyses. Plus and minus characters indicate increased
and decreased connectivity between brain regions in MDD. ACC =
anterior cingulate cortex; Amyg = amygdala; DLPFC = dorsolateral
prefrontal cortex; OFC = orbitofrontal cortex; suprag = supragenual;
subg = subgenual.
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well as increased FC to the DLPFC. The two available
EC studies [47,48] in MDD patients further specified the
directionality of these brain abnormalities. Both studies
indicate reduced left-sided connectivity between the
O F Ca n dt h ea m y g d a l ai np a t i e n t s ,b u ts h o w ,a tf i r s t
glance, contradictory results with regard to the direction
of influence on another (top down vs bottom up). In
both paradigms participants were instructed to explicitly
label emotions, but different paradigms were used (face-
matching task vs morphed facial expression processing
paradigm); therefore this may be, next to medication
effects, one reason explaining the results. Future studies
are needed to further investigate on this issue.
The OFC is a central part of the frontosubcortical cir-
cuits, connecting the frontal and limbic systems with
each other, and is crucial for mood regulatory processes
[97,98]. Relative uncoupling of connections between
heightened activity in the limbic system and the OFC
during negative facial processing in MDD may account
for depressive symptoms such as negative emotional
experiences and impaired regulation of emotional and
social behavior [41]. Increased FC between OFC and lat-
eral PFC systems could be the neural substrate of a
more voluntary compensatory mechanism in MDD [99]
for the described altered automatic emotional face
processing.
Unresolved questions
To date, it is not clear whether the neurobiological
abnormalities described above represent state or trait
markers of depression. As highlighted above, a few stu-
dies have demonstrated a normalization of abnormal
neurobiological response patterns after antidepressant
medication (for example, [29,32]). Moreover, these stu-
dies are in line with several pharmaco-fMRI studies in
healthy subjects, showing that limbic responsiveness to
negative facial stimuli can be attenuated even by short-
term antidepressant administration [100-102]. However,
although it seems that antidepressants modify pathologi-
cal emotional face processing in depression, it still
remains to be clarified whether these functional
abnormalities in emotional face processing represent a
feature of acute depressed state and would therefore
also resolve without medication after remission or
whether they represent a risk factor preceding the onset
of depression. The first studies in remitted patients and
in high-risk subjects [36,65,68,69,71,103], as well as data
from imaging genetics and twin studies [73-78] suggest
that amygdala responsiveness to emotional faces as well
as amygdala-prefrontal and amygdala-ACC connectivity
may represent vulnerability factors for MDD.
A second unresolved question concerns possible later-
ality effects of valence-specific emotion processing in
the depressed brain. Although this aspect may be raised
by the data, it was not the focus of our analysis and still
needs further clarification. As noted above, other unre-
solved issues concern the heterogeneity of presentation
paradigms. For example, studies investigating automatic
facial emotion processing are likely to target other brain
areas compared to explicit emotion processing para-
digms. Obviously, this is particularly important for
investigating prefrontal areas and might explain the
apparently contradictive results in brain areas involved
in emotion regulation, for example the DLPFC. Next to
the methodological aspect, variability between patient
samples due to different symptom characteristics may
be a further critical, influential factor. Age, comorbidity,
treatment history, number of prior episodes or age on
illness onset may confound the reported results [7].
Unfortunately, information about clinical variables was
provided by less than half of the reviewed studies, leav-
ing these variables relatively uncontrolled for in this
review and therefore limiting the described results and
their interpretation. As described in the Discussion sec-
tion, differences in medication status and low sample
sizes could further contribute to inconsistencies among
study results.
The research field would benefit from larger studies
with well characterized patient samples (that is, detailed
description of clinical variables), particularly multicenter
studies. Furthermore, investigators should carry on
employing standardized paradigms in order to replicate
results and to resolve conflicting findings. For example,
the comparison of subliminal and supraliminal stimulus
presentation in one patient sample and the influence of
attentional mechanisms on a neural level are still rarely
investigated. Future studies should explicitly focus on
group × valence interactions in factorial designs to
explore differential effects of valence and should use
connectivity analysis strategies (FC and/or EC) to
describe the interplay of core regions such as the amyg-
dala, ACC and OFC more precisely. Longitudinal stu-
dies, including relatives or other high-risk subjects are
very essential and may ultimately answer the question if
the described anomalies represent ‘trait’ or ‘state’ marker
of depression.
Finally, one should notice that facial processing is only
one aspect of altered cognitive/emotional processing
among several others in MDD described by behavioral
(for review see [104]) and neuroimaging (for review see
[7]) studies. Thus, one must caution against overinter-
pretation of the presented results on altered neural facial
processing in MDD.
Conclusions
Based on cognitive models of depression and behavioral
studies pointing to an emotion processing bias in acute
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gated the neuronal underpinnings of these emotional
processing abnormalities. It has been shown that the use
of emotional face processing tasks is a reliable and valid
approach to pinpoint most if not all relevant areas. The
analysis of neural activation data shows that MDD
patients are characterized by abnormalities within the
common face processing network, indicating a mood-
congruent processing bias particularly in the amygdala,
insula and PHG, fusiform face area and putamen
responsiveness. Furthermore, abnormalities in the cingu-
late gyrus and OFC are obvious, which are refined by
investigations implementing functional connectivity ana-
lysis. A pathologically altered emotion processing and
emotion regulation network emerged, including the
amygdala, the ACC, OFC and DLPFC as core compo-
nents. Further neuroimaging studies will be needed to
extend these findings, especially by replicating data with
same activation paradigms and larger sample sizes in
order to enable researchers to make more valid assump-
tions on neural emotional processing mechanisms, con-
tributing to a better understanding of depressive
disorders.
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